Proficio Capital Partners LLC bought a new stake in Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the ...

Paul Kim, the CFO and Treasurer of $FLGT, bought 100,000 shares of the company on 03-05-2025 for an estimated $1,596,470. This trade was reported by Quiver ...

Fulgent Genetics, Inc. (FLGT) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of a loss of $0.12 per share. This compares to earnings of $0.28 per share a ...

UBS analyst Dan Leonard lowered the firm’s price target on Fulgent Genetics (FLGT) to $20 from $27 and keeps a Neutral rating on the shares.

StockNews.com upgraded shares of Fulgent Genetics (NASDAQ:FLGT – Free Report) from a sell rating to a hold rating in a research report released on Wednesday. Separately, Piper Sandler decreased their ...

Fulgent Genetics ( NASDAQ:FLGT ) Full Year 2024 Results Key Financial Results Revenue: US$283.5m (down 2.0% from FY... EL MONTE, Calif., February 28, 2025--Fulgent Genetics, Inc. (NASDAQ ...

FULGENT GENETICS ($FLGT) posted quarterly earnings results on Friday, February 28th. The company reported earnings of $0.04 per share, beating estimates of -$0.13 by ...

Piper Sandler analyst David Westenberg lowered the firm’s price target on Fulgent Genetics (FLGT) to $16 from $22 following quarterly results.

Fulgent Genetics Inc (NASDAQ: FLGT) reported Q2 sales of $68 million, beating the consensus estimate of $62.68 million.< ...